« CTSNet Online Books
LUNG CANCER
A Handbook for Staging, Imaging, and Lymph Node Classification
by Clifton F. Mountain, MD; Herman I. Libshitz, MD; and Kay E. Hermes
Contents | About the Author(s) | Dedication and Acknowledgment
 References
page 70 - 71 
  1. Mountain CF: A new international system for staging lung cancer. Chest 1986;89:225s-33s.


  2. American Joint Committee on Cancer (AJCC): Lung. In Beahrs OH, Hensen DE, Hutter RVP, et al (eds): Manual for Staging of Cancer, 4th ed., Philadelphia, JB Lippincott, 1992, p 120.


  3. International Union Against Cancer (UICC): Lung tumors (ICD-0-162). In Hermanek P, Sobin LH, (eds): TNM Classification of Malignant tumors, 4th ed. Berlin, Springer- Verlag, 1987, p 89.


  4. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-17.


  5. Mountain CF, Dresler CM: Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.


  6. American Joint Committee on Cancer (AJCC): Lung. In Fleming ID, Cooper JS, Hensen DE, et al.(eds): Cancer staging manual, 5th ed., Philadelphia, Lippincott-Raven, 1997, p 127.


  7. International Union Against Cancer (UICC): Lung and Pleural Tumors. In Hermanek P, Hutter RVP, Sobin L (eds): TNM Atlas, 4th ed. (Illustrated guide to the TNM/pTNM classification) New York, Wiley-Liss, Inc., 1997.


  8. International Union Against Cancer (UICC): Lung (ICD-O C-34). In Sobin LH, Wittekind CH (eds): TNM classification of malignant tumors. 5th ed. New York, Wiley-Liss, 1997.


  9. Kwiatowski DJ, Harpole DH,Jr., Godleski JU, Herndon JE, 2nd, Shieh DB, Richards W, Blanco R, Xu HJ, Strauss GM, Sugarbaker DJ: Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications. J Clin Oncol 1998;16(7):2469-77.


  10. Fontanni G, DeLaurentis M, Vignati S, Chine S, Lucchi M, Silvestri V, Mussi A, De Placido S, Tortora G, Bianco AR, Gullick W, Angelletti CA, Bevilacqua G, Ciardiello F: Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 1998;4(1):241-9.


  11. Kawaguchi T, Yamamoto S, Kudoh S, Goto K, Wakasa K, Sakurai M: Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma. Anticancer Res 1997;17(5B):3743-6.


  12. Mountain CF: Expanded possibilities for surgical treatment of lung cancer. Chest 1990;97:1045-51.


  13. Weber W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthness GK, Steinert HC: Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998;66:886-92.


  14. Passlick BK, Thetter O: Lymph node documentation and lymphadenectomy in bronchial carcinomas. Results of a survey in Germany. Chirug 1997;68(6):601-5.


  15. Naruke T, Suemasu K, Ishikawa S: Lymph node mapping and curability of various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-39.


  16. American Thoracic Society (ATS): Clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127:1-6.


  17. Libshitz HI: Computed tomography in bronchogenic carcinoma. Semin Roentgenol 1990;25(1):64-72.


  18. Libshitz HI: Imaging and staging of lung cancer. Curr Opin Radiol 1989;1(1):21-4.


  19. McKenna RJ, Libshitz HI, Mountain CF, McMurtrey MJ: Roentgenologic evaluation of mediastinal nodes for preoperative assessment in lung cancer. Chest 1985;88:206-210.


  20. Jamadar DA, Gross BH: Radiologic staging of lung cancer. Semin Respir Med Crit Care Med 1998;19(5)493-503.


  21. Huang CL, Taki T, Adachi M, Konishi T, Higashiyama M, Kinoshita M, Hadama T, Miyake M: Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer. Int J Oncol 1998;12(3):553-63.


  22. Van Zandwijk N, Van't Veer LJ: The role of prognostic factors and oncogenes in the detection and management of non-small cell lung cancer. Oncol (Huntingt) 1998;12(Suppl 2):55-9.


  23. Mountain CF: New prognostic factors in lung cancer. Biologic prophets of cancer cell agression. Chest 1995;108:246-254.


  24. Darling GE: Staging of the patient with small cell lung cancer. Chest Surg Clin N Am 1997;7(1):81-94.


  25. Gehan EA: statistical methods for survival time studies. In Staquet MJ (ed): Cancer therapy, prognostic factors and criteria of response. New York, Raven Press, 1975, p 7-35.
« previous page    
Copyright © 1999 - 2003 by CF Mountain and HI Libshitz, Houston, Texas. All rights reserved.

Printed in the United States of America by Charles P. Young Company. No part of this manual may be reproduced by any means without the prior written consent of the authors.